Compound Holdings I
Chicago, US · Founded 2013
Founders & leadership
SC
Scott CharlesExecutive
WS
William ScheinlerExecutive
SR
Stephen RossExecutive
LS
Lien-Lung SheuExecutive
JS
Joseph StaufferExecutive
AK
Anatasios KonidarisExecutive
DT
Daniel TasseExecutive
MA
Michael AdasczikExecutive
DG
Douglas GreeneExecutive
Board
EB
Elizabeth BettenBoard director
NA
Nicholas AlexosBoard director
JS
Jason ShidelerBoard director
Reported raises · per SEC filings
Form D private placements$412M disclosed across 1 round · 2014
▶$412MraisedFeb 2014 · 178 investors · PharmaceuticalsRule 506(b)
▶$412MraisedFeb 2014 · 178 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Elizabeth BettenDirector
- Scott CharlesExecutive Officer
- William ScheinlerExecutive Officer
- Stephen RossExecutive Officer
- Lien-Lung SheuExecutive Officer
- Nicholas AlexosDirector
- Joseph StaufferExecutive Officer
- Jason ShidelerDirector
- Anatasios KonidarisExecutive Officer
- Daniel TasseExecutive Officer, Director
- Michael AdasczikExecutive Officer
- Douglas GreeneExecutive Officer
- Jonathan ProvoostExecutive Officer
- Matthew BennettExecutive Officer
- James BriggsExecutive Officer
- Timothy SullivanDirector
- Matthew HoltDirector
- Offering amount
- $412M
- Amount sold
- $412M
- Proceeds to insiders
- $65M
- First sale
- Feb 2014
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Compound Holdings I raised?
- Compound Holdings I has disclosed $412M raised across 1 round.
- Where is Compound Holdings I headquartered?
- Compound Holdings I is headquartered in Chicago, US.